MAPK14 and amyotrophic lateral sclerosis: Therefore, targeting signaling pathways between mSOD1 and p38 represent a promising new direction for therapeutic intervention in ALS, particularly since this pathway is also implicated in some SALS cases [23], and brain-permeable p38 kinase inhibitors exist [45].